Equities

Century Therapeutics Inc

IPSC:NSQ

Century Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.62
  • Today's Change-0.08 / -4.71%
  • Shares traded262.22k
  • 1 Year change-27.68%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 18:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments173315223
Total Receivables, Net------
Total Inventory------
Prepaid expenses4.264.004.77
Other current assets, total00.220.50
Total current assets177320228
Property, plant & equipment, net9211270
Goodwill, net------
Intangibles, net------
Long term investments8952136
Note receivable - long term------
Other long term assets--00.22
Total assets361487437
LIABILITIES
Accounts payable2.745.457.60
Accrued expenses109.846.04
Notes payable/short-term debt000
Current portion long-term debt/capital leases06.501.04
Other current liabilities, total4.988.020.98
Total current liabilities183016
Total long term debt03.748.90
Total debt0109.94
Deferred income tax------
Minority interest------
Other liabilities, total15815017
Total liabilities17618441
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital840824785
Retained earnings (accumulated deficit)(656)(519)(388)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.11(2.46)(0.65)
Total equity185303396
Total liabilities & shareholders' equity361487437
Total common shares outstanding605855
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.